Oxford–AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign-Reference-Cited by-同舟云学术

Oxford–AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign

Published:2021-07 Issue: Volume:196 Page:135-137
ISSN:0033-3506
Container-title:Public Health
language:en
Short-container-title:Public Health

Author:

Vallée A.,Chan-Hew-Wai A.,Bonan B.,Lesprit P.,Parquin F.,Catherinot É.,Choucair J.,Billard D.,Amiel-Taieb C.,Camps È.,Cerf C.,Zucman D.,Fourn E.

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,General Medicine

Reference10 articles.

1. COVID-19 herd immunity: where are we?;Fontanet;Nat Rev Immunol,2020

2. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials;Voysey;Lancet Lond Engl,2021

3. Epidemiology and risk factors for venous thrombosis;Cushman;Semin Hematol,2007

4. COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine's benefits currently still outweigh risks Update [Internet],2021

5. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK;Voysey;Lancet Lond Engl,2021

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 Adenoviral Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), COVID-19-Related Thrombosis, and the Thrombotic Thrombocytopenic Syndromes;Hematology Reports;2022-12-01

2. The public health and the question of the “best vaccine”;Vaccine;2022-06

3. Vaccines for Covid‐19: An insight on their effectiveness and adverse effects;Journal of Medical Virology;2022-05-05

4. Safety of Global SARS-CoV-2 Vaccines, a Meta-Analysis;Vaccines;2022-04-12

5. Analysis of collaboration between AstraZeneca and the higher education sector in the UK;Industry and Higher Education;2022-04-06